cyclobenzaprine 5 mg

INDICATIONS AND USAGE Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to 2 or 3 weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. Cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.

trupharma llc

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] pain` `[4] dyspnoea` `[5] nausea` `[6] off label use` `[7] diarrhoea` `[8] rash` `[9] headache` `[10] abdominal discomfort`

5 years ago

ROUND YELLOW 020

HOW SUPPLIED

CYCLOBENZAPRINE HYDROCHLORIDE Tablets, USP are available containing 5 mg, 7.5 mg or 10 mg of

CYCLOBENZAPRINE HYDROCHLORIDE, USP. The 5 mg tablets are butter scotch yellow film-coated, round tablets debossed with 020 on one side and plain on other side. They are available as follows: NDC 52817-330-10 bottles of 100 tablets NDC 52817-330-50 bottles of 500 tablets The 7.5 mg tablets are white to off-white film-coated, round tablets debossed with 021 on one side and plain on other side. They are available as follows: NDC 52817-331-10 bottles of 100 tablets The 10 mg tablets are orange-yellow film-coated, round tablets debossed with 022 on one side and plain on other side. They are available as follows: NDC 52817-332-10 bottles of 100 tablets NDC 52817-332-00 bottles of 1000 tablets NDC 52817-332-50 bottles of 500 tablets Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Distributed By: TruPharma, LLC Tampa,FL 33609 Manufactured by: Rubicon Research Private Limited, Ambernath,Dist. Thane,421506 India Rev. 02, June 2018

More pills like ROUND 020

Related Pills

Cyclobenzaprine 7.5 mg

TruPharma LLC

Cyclobenzaprine hydrochloride 10 MG Oral Tablet

TruPharma LLC

cyclobenzaprine 5 mg

trupharma llc